References:
[1]
(2005) Tuberculosis bacteriology--priorities and indications in high prevalence
countries: position of the technical staff of the Tuberculosis Division of the
International Union Against Tuberculosis and Lung Disease. Int J Tuberc Lung Dis 9, 355-361.
[2]
Addo K., Owusu-Darko K., Yeboah-Manu D., Caulley P., Minamikawa M., Bonsu F.,
Leinhardt C., Akpedonu P. and Ofori-Adjei D. (2007) Mycobacterial species
causing pulmonary tuberculosis at the korle bu teaching hospital, accra, ghana.
Ghana Med J 41, 52-57.
[3]
Addo K.K., Dan-Dzide M., Yeboah-Manu D., Owusu-Darko K., Caulley P., Minamikawa
M., Bonsu F., Lienhardt C., Akpedonu P. and Ofori-Adjei D. (2006) Improving the
laboratory diagnosis of TB in Ghana: the impact of a quality assurance system. Int J Tuberc Lung Dis 10, 812-817.
[4]
Adeleye I.A., Onubogu C.C., Ayolabi C.I., Isawumi A.O. and Nshiogu M.E. (2008)
Screening of crude extracts of twelve medicinal plants and “wonder-cure”
concoction used in Nigeria unorthodox medicine for activity against
Mycobacterium tuberculosis isolated from tuberculosis patients’ sputum. African Journal of Biotechnology 7,
3182-3187.
[5]
Aziz M., Becx-Bleumink B.F., Bretzel G., Humes R. and Iademarco M.F. (2002)
External quality assessment for AFB smear microscopy. Washington: Association
of Public Health Laboratories.
[6]
Aziz M. and Bretzel G. (2002) Use of a standardised checklist to assess
peripheral sputum smear microscopy laboratories for tuberculosis diagnosis in
Uganda. Int J Tuberc Lung Dis 6,
340-349.
[7]
Aziz M.A., Rysweska K., Laszlo A. and Blanc L. (2006) Strategic approach for
the strengthening of laboratory services for tuberculosis control, 2006-2009.
Geneva: WHO.
[8]
Baghdadi J.E., Orlova M., Alter A., Ranque B., Chentoufi M., Lazrak F., Archane
M.I., Casanova J.L., Benslimane A., Schurr E. and Abel L. (2006) An autosomal
dominant major gene confers predisposition to pulmonary tuberculosis in adults.
J Exp Med 203, 1679-1684.
[9]
Banerji D. and Andersen S. (1963) A Sociological Study of Awareness of Symptoms
among Persons with Pulmonary Tuberculosis. Bull
World Health Organ 29, 665-683.
[10]
Barnes D.S. (1995) The Making of a Social
Disease: Tuberculosis in Nineteenth-century France. . University of
California Press.
[11]
Bass J.B., Jr. (1989) The face of TB changes again. Hosp Pract (Off Ed) 24, 81-85, 88, 93-85, passim.
[12]
Becker M.H. (1985) Patient adherence to prescribed therapies. Med Care 23, 539-555.
[13]
Blaak E. (2001) Gender differences in fat metabolism. Curr Opin Clin Nutr Metab Care 4, 499-502.
[14]
Bonah C. (2005) The 'experimental stable' of the BCG vaccine: safety, efficacy,
proof, and standards, 1921-1933. Stud
Hist Philos Biol Biomed Sci 36, 696-721.
[15]
Borgdorff M.W., Nagelkerke N.J., Dye C. and Nunn P. (2000) Gender and
tuberculosis: a comparison of prevalence surveys with notification data to
explore sex differences in case detection. Int
J Tuberc Lung Dis 4, 123-132.
[16]
Bustamante J., Picard C., Fieschi C., Filipe-Santos O., Feinberg J., Perronne
C., Chapgier A., de Beaucoudrey L., Vogt G., Sanlaville D., Lemainque A., Emile
J.F., Abel L. and Casanova J.L. (2007) A novel X-linked recessive form of
Mendelian susceptibility to mycobaterial disease. J Med Genet 44, e65.
[17]
Calippe B., Douin-Echinard V., Laffargue M., Laurell H., Rana-Poussine V., Pipy
B., Guery J.C., Bayard F., Arnal J.F. and Gourdy P. (2008) Chronic estradiol
administration in vivo promotes the proinflammatory response of macrophages to
TLR4 activation: involvement of the phosphatidylinositol 3-kinase pathway. J Immunol 180, 7980-7988.
[18]
Chrisman N. and Kleinman A. (1983) Popular health care, social networks, and
cultural meanings: the orientation of medical anthropology. In Handbook of health, health care, and the
health professions,, pp. 569-590 [D. Mechanic, editor]. New York: The Free
Press.
[19]
Comstock G.W. (1994) The International Tuberculosis Campaign: a pioneering
venture in mass vaccination and research. Clin
Infect Dis 19, 528-540.
[20]
Curry F.J. (1968) Neighborhood clinica for more effective outpatient treatment
of tuberculosis. N Engl J Med 279,
1262-1267.
[21]
Daniel T.M. (1982) Selective primary health care: strategies for control of
disease in the developing world. II. Tuberculosis. Rev Infect Dis 4, 1254-1265.
[22]
Daniel T.M. (2004) The impact of tuberculosis on civilization. Infect Dis Clin North Am 18, 157-165.
[23]
Davila S., Hibberd M.L., Hari Dass R., Wong H.E., Sahiratmadja E., Bonnard C.,
Alisjahbana B., Szeszko J.S., Balabanova Y., Drobniewski F., van Crevel R., van
de Vosse E., Nejentsev S., Ottenhoff T.H. and Seielstad M. (2008) Genetic
association and expression studies indicate a role of toll-like receptor 8 in
pulmonary tuberculosis. PLoS Genet 4,
e1000218.
[24]
Deuschle K. and Adair J. (1960) An interdisciplinary approach to public health
on the Navajo Indian reservation: medical and anthropological aspects. Ann NY Acad Sci 17, 887-905.
[25]
Drobniewski F.A., Caws M., Gibson A. and Young D. (2003) Modern laboratory
diagnosis of tuberculosis. Lancet Infect
Dis 3, 141-147.
[26]
Drobniewski F.A., Hoffner S., Rusch-Gerdes S., Skenders G. and Thomsen V.
(2006) Recommended standards for modern tuberculosis laboratory services in
Europe. Eur Respir J 28, 903-909.
[27]
Dubos R.J. and Jean D. (1987) The White
Plague: Tuberculosis, Man, and Society. Rutgers University Press.
[28]
Ebara R.V.B., Madunagu E.U. and Otung I.N. (1990) Microbiological exploitation
of Cardiac Glycosides and Alkaloids from Garcinia kola and Borreriaocymoides. J. Bacteriol 871, 398-401.
[29]
Fortin A., Abel L., Casanova J.L. and Gros P. (2007) Host genetics of
mycobacterial diseases in mice and men: forward genetic studies of BCG-osis and
tuberculosis. Annu Rev Genomics Hum Genet
8, 163-192.
[30]
Fox W. (1983) Compliance of patients and physicians: experience and lessons
from tuberculosis-I. Br Med J (Clin Res
Ed) 287, 33-35.
[31]
Friemodt-Moller J. (1968) Domiciliary drug therapy of pulmonary tuberculosis in
a rural population in India. Tubercle
49 (supp.), 22-23.
[32]
Gangadharam P.R.J., Reichmann L.B. and Hershfield E.S. (1993) Drug resistance
in tuberculosis. In A Comprehensive
International Approach, pp. 293-328. [M. Deke, editor].
[33]
Gordon S. and Rylance J. (2009) Where there's smoke... there's tuberculosis. Thorax 64, 649-650.
[34]
Grossman C.J. (1985) Interactions between the gonadal steroids and the immune
system. Science 227, 257-261.
[35]
Haefner D.P. and Kirscht J.P. (1970) Motivational and behavioral effects of
modifying health beliefs. Public Health
Rep 85, 478-484.
[36]
Hamid Salim M.A., Declercq E., Van Deun A. and Saki K.A. (2004) Gender
differences in tuberculosis: a prevalence survey done in Bangladesh. Int J Tuberc Lung Dis 8, 952-957.
[37]
Hargreaves N.J., Kadzakumanja O., Whitty C.J., Salaniponi F.M., Harries A.D.
and Squire S.B. (2001) 'Smear-negative' pulmonary tuberculosis in a DOTS
programme: poor outcomes in an area of high HIV seroprevalence. Int J Tuberc Lung Dis 5, 847-854.
[38]
Hawken M.P., Muhindi D.W., Chakaya J.M., Bhatt S.M., Ng'ang'a L.W. and Porter
J.D. (2001) Under-diagnosis of smear-positive pulmonary tuberculosis in
Nairobi, Kenya. Int J Tuberc Lung Dis
5, 360-363.
[39]
Herrera M., Senties R., Esquivel E. and Armas J. (1971) [Social problems of the
tuberculosis patient in long term care hospitals]. Salud Publica Mex 13, 749-762.
[40]
Hill A.V. (2006) Aspects of genetic susceptibility to human infectious
diseases. Annu Rev Genet 40, 469-486.
[41]
Hochbaum G.M. (1956) Why people seek diagnostic x-rays. Public Health Rep 71, 377-380.
[42]
Holmes C.B., Hausler H. and Nunn P. (1998) A review of sex differences in the
epidemiology of tuberculosis. Int J
Tuberc Lung Dis 2, 96-104.
[43]
Hunt L.M., Jordan B., Irwin S. and Browner C.H. (1989) Compliance and the
patient's perspective: controlling symptoms in everyday life. Cult Med Psychiatry 13, 315-334.
[44]
Janele D., Lang T., Capellino S., Cutolo M., Da Silva J.A. and Straub R.H.
(2006) Effects of testosterone, 17beta-estradiol, and downstream estrogens on
cytokine secretion from human leukocytes in the presence and absence of
cortisol. Ann N Y Acad Sci 1069,
168-182.
[45]
Janz N.K. and Becker M.H. (1984) The Health Belief Model: a decade later. Health Educ Q 11, 1-47.
[46]
Jasmer R.M., Roemer M., Hamilton J., Bunter J., Braden C.R., Shinnick T.M. and
Desmond E.P. (2002) A prospective, multicenter study of laboratory
cross-contamination of Mycobacterium tuberculosis cultures. Emerg Infect Dis 8, 1260-1263.
[47]
Kendall C. and Thoits P. The impact of culture on the cognitive structure of
illness. Cult Med Psychiatry 11,
465-494.
[48]
Khan M.S., Dar O., Sismanidis C., Shah K. and Godfrey-Faussett P. (2007)
Improvement of tuberculosis case detection and reduction of discrepancies
between men and women by simple sputum-submission instructions: a pragmatic
randomised controlled trial. Lancet
369, 1955-1960.
[49]
Kochi A. (1991) The global tuberculosis situation and the new control strategy
of the World Health Organization. Tubercle
72, 1-6.
[50]
Kopanoff D.E., Snider D.E., Jr. and Johnson M. (1988) Recurrent tuberculosis:
why do patients develop disease again? A United States Public Health Service
cooperative survey. Am J Public Health
78, 30-33.
[51]
Kumate J. (1990) Las enfermedadestransmisibles. In Salud y crisis en Mexico, pp. 17-39 [SigloVeintiuno, editor. Mexico
City: I. Almada Bay.
[52]
Kusznierz G.F., Latini O.A. and Sequeira M.D. (2004) Quality assessment of
smear microscopy for acid-fast bacilli in the Argentine tuberculosis laboratory
network, 1983-2001. Int J Tuberc Lung Dis
8, 1234-1241.
[53]
Laszlo A., Rahman M., Espinal M. and Raviglione M. (2002) Quality assurance
programme for drug susceptibility testing of Mycobacterium tuberculosis in the
WHO/IUATLD Supranational Reference Laboratory Network: five rounds of
proficiency testing, 1994-1998. Int J
Tuberc Lung Dis 6, 748-756.
[54]
Leff A.R. and Leff D.R. (1986) Tuberculosis: a reflection of political
institutions and social concerns in the United States. Perspect Biol Med 30, 27-39.
[55]
Leone M., Honstettre A., Lepidi H., Capo C., Bayard F., Raoult D. and Mege J.L.
(2004) Effect of sex on Coxiella burnetii infection: protective role of
17beta-estradiol. J Infect Dis 189,
339-345.
[56]
Lieban R.W. (1976) Traditional medical beliefs and the choice of practitioners
in a Philippine city. Soc Sci Med 10,
289-296.
[57]
Lienhardt C., Fielding K., Sillah J.S., Bah B., Gustafson P., Warndorff D.,
Palayew M., Lisse I., Donkor S., Diallo S., Manneh K., Adegbola R., Aaby P.,
Bah-Sow O., Bennett S. and McAdam K. (2005) Investigation of the risk factors
for tuberculosis: a case-control study in three countries in West Africa. Int J Epidemiol 34, 914-923.
[58]
Lin C.M., Davidson T.M. and Ancoli-Israel S. (2008) Gender differences in obstructive
sleep apnea and treatment implications. Sleep
Med Rev 12, 481-496.
[59]
Liu P.T., Stenger S., Li H., Wenzel L., Tan B.H., Krutzik S.R., Ochoa M.T.,
Schauber J., Wu K., Meinken C., Kamen D.L., Wagner M., Bals R., Steinmeyer A.,
Zugel U., Gallo R.L., Eisenberg D., Hewison M., Hollis B.W., Adams J.S., Bloom
B.R. and Modlin R.L. (2006) Toll-like receptor triggering of a vitamin
D-mediated human antimicrobial response. Science
311, 1770-1773.
[60]
Marriott I. and Huet-Hudson Y.M. (2006) Sexual dimorphism in innate immune
responses to infectious organisms. Immunol
Res 34, 177-192.
[61]
Martin R., Hearn T.L., Ridderhof J.C. and Demby A. (2005) Implementation of a
quality systems approach for laboratory practice in resource-constrained
countries. AIDS 19 Suppl 2, S59-65.
[62]
Martinez A., Balandrano S., Parissi A., Zuniga A., Sanchez M., Ridderhof J.,
Lipman H.B. and Madison B. (2005) Evaluation of new external quality assessment
guidelines involving random blinded rechecking of acid-fast bacilli smears in a
pilot project setting in Mexico. Int J
Tuberc Lung Dis 9, 301-305.
[63]
Mata J.I. (1985) Integrating the client's perspective in planning a
tuberculosis education and treatment program in Honduras. Med Anthropol 9, 57-64.
[64]
Maulitz R.C. and Maulitz S.R. (1973) The King's Evil in Oxfordshire. Med Hist 17, 87-89.
[65]
McCarthy O.R. (2001) The key to the sanatoria. J R Soc Med 94, 413-417.
[66]
McClelland C. (1909) "Galen on Tuberculosis".The Physician and
Surgeon. Detroit and Ann Arbor: Keating
and Bryant 31, 400-404.
[67]
Miller E.N., Jamieson S.E., Joberty C., Fakiola M., Hudson D., Peacock C.S.,
Cordell H.J., Shaw M.A., Lins-Lainson Z., Shaw J.J., Ramos F., Silveira F. and
Blackwell J.M. (2004) Genome-wide scans for leprosy and tuberculosis
susceptibility genes in Brazilians. Genes
Immun 5, 63-67.
[68]
Moysen J.S. and Arroyo Acevedo P. (1984) Critica de la validez de los metodos
de deteccion y confirmacion de la tuberculosis pulmonarcomo un problema de
saludpublica. SaludPublica de Mexico
26, 546-555.
[69]
Mundy C.J., Harries A.D., Banerjee A., Salaniponi F.M., Gilks C.F. and Squire
S.B. (2002) Quality assessment of sputum transportation, smear preparation and
AFB microscopy in a rural district in Malawi. Int J Tuberc Lung Dis 6, 47-54.
[70]
Munyati S.S., Dhoba T., Makanza E.D., Mungofa S., Wellington M., Mutsvangwa J.,
Gwanzura L., Hakim J., Nyakabau M., Mason P.R., Robertson V., Rusakaniko S.,
Butterworth A.E. and Corbett E.L. (2005) Chronic cough in primary health care
attendees, Harare, Zimbabwe: diagnosis and impact of HIV infection. Clin Infect Dis 40, 1818-1827.
[71]
Nashold F.E., Spach K.M., Spanier J.A. and Hayes C.E. (2009) Estrogen controls
vitamin D3-mediated resistance to experimental autoimmune encephalomyelitis by
controlling vitamin D3 metabolism and receptor expression. J Immunol 183, 3672-3681.
[72]
Ober C., Loisel D.A. and Gilad Y. (2008) Sex-specific genetic architecture of
human disease. Nat Rev Genet 9,
911-922.
[73]
Pamra S.P. (1980) Problems of tuberculosis in developing countries. Clin Chest Med 1, 265-271.
[74]
Perkins M.D., Roscigno G. and Zumla A. (2006) Progress towards improved
tuberculosis diagnostics for developing countries. Lancet 367, 942-943.
[75]
Petti C.A., Polage C.R., Quinn T.C., Ronald A.R. and Sande M.A. (2006)
Laboratory medicine in Africa: a barrier to effective health care. Clin Infect Dis 42, 377-382.
[76]
Pitchenik A.E. (1984) Monitoring compliance with anti-tuberculosis therapy. N Engl J Med 311, 799.
[77]
Ridderhof J.C., Williams L.O., Legois S., Shult P.A., Metchock B., Kubista
L.N., Handsfield J.H., Fehd R.J. and Robinson P.H. (2003) Assessment of
laboratory performance of nucleic acid amplification tests for detection of
Mycobacterium tuberculosis. J Clin
Microbiol 41, 5258-5261.
[78]
Rieder H.L., Arnadottir T., Tardencilla Gutierrez A.A., Kasalika A.C.,
Salaniponi F.L., Ba F., Diop A.H., Anagonou S., Gninafon M., Ringdal T.,
Trebucq A. and Enarson D.A. (1997) Evaluation of a standardized recording tool
for sputum smear microscopy for acid-fast bacilli under routine conditions in
low income countries. Int J Tuberc Lung
Dis 1, 339-345.
[79]
Roberts C.W., Walker W. and Alexander J. (2001) Sex-associated hormones and
immunity to protozoan parasites. Clin
Microbiol Rev 14, 476-488.
[80]
Roden A.C., Moser M.T., Tri S.D., Mercader M., Kuntz S.M., Dong H., Hurwitz
A.A., McKean D.J., Celis E., Leibovich B.C., Allison J.P. and Kwon E.D. (2004)
Augmentation of T cell levels and responses induced by androgen deprivation. J Immunol 173, 6098-6108.
[81]
Rosenstock I.M. (1974) Historical origins of the health belief model. In The health belief model and personal health
behavior, pp. 1-8 [M.H. Becker and C.B. Slack, editors]. Thorofare, NJ.
[82]
Rubel A.J. and Garro L.C. (1992) Social and cultural factors in the successful
control of tuberculosis. Public Health
Rep 107, 626-636.
[83]
Rubel A.J. and O'Nell C.W. (1978) Difficulties of presenting complaints to
physicians: susto illness as an example. In Modern
medicine and medical anthropology in the United States-Mexico border population,
pp. 147-154 [B. Velimirovic, editor]. Washington, DC: Pan American Health Organization.
[84]
Ryan K.J. and Ray C.G. (2004) Sherris
Medical Microbiology.
[85]
San Antonio-Gaddy M., Richardson-Moore A., Burstein G.R., Newman D.R., Branson
B.M. and Birkhead G.S. (2006) Rapid HIV antibody testing in the New York State
Anonymous HIV Counseling and Testing Program: experience from the field. J Acquir Immune Defic Syndr 43, 446-450.
[86]
Schaible U.E., Collins H.L., Priem F. and Kaufmann S.H. (2002) Correction of
the iron overload defect in beta-2-microglobulin knockout mice by lactoferrin
abolishes their increased susceptibility to tuberculosis. J Exp Med 196, 1507-1513.
[87]
Shinnick T.M., Lademarco M. and Ridderhof J.C. (2005) National Plan for
Reliable Tuberculosis Laboratory Services Using a Systems Approach:
Recommendations from CDC and the Association of Public Health Laboratories Task
Force on Tuberculosis Laboratory Services. MMWR
Morb Mortal Wkly Rep 541, 12.
[88]
Slutkin G. (1986) Management of tuberculosis in urban homeless indigents. Public Health Rep 101, 481-485.
[89]
Small P.M., McClenny N.B., Singh S.P., Schoolnik G.K., Tompkins L.S. and
Mickelsen P.A. (1993) Molecular strain typing of Mycobacterium tuberculosis to
confirm cross-contamination in the mycobacteriology laboratory and modification
of procedures to minimize occurrence of false-positive cultures. J Clin Microbiol 31, 1677-1682.
[90]
Styblo K. (1989) Overview and epidemiologic assessment of the current global
tuberculosis situation with an emphasis on control in developing countries. Rev Infect Dis 11 Suppl 2, S339-346.
[91]
Sudre N., ten Dam G. and Kochi A. (1991) Tuberculosis in the present time: a
global overview of the tuberculosis situation. Geneva: World Health
Organization.
[92]
Tsuyuguchi K., Suzuki K., Matsumoto H., Tanaka E., Amitani R. and Kuze F.
(2001) Effect of oestrogen on Mycobacterium avium complex pulmonary infection
in mice. Clin Exp Immunol 123, 428-434.
[93]
Tuberculosis Research Centre M., and National Tuberculosis Institute, Bangalore
(1984) A controlled clinical trial of 3- and 5-month regimes in the treatment
of sputum positive pulmonary tuberculosis. Ann
Rev Respir Dis 130, 1091-1094.
[94]
Van Deun A., Kim S.J. and Rieder H.L. (2005) Will the bleach method keep its
promise in sputum smear microscopy? Int J
Tuberc Lung Dis 9, 700; author reply 700-701.
[95]
Van Deun A. and Portaels F. (1998) Limitations and requirements for quality
control of sputum smear microscopy for acid-fast bacilli. Int J Tuberc Lung Dis 2, 756-765.
[96]
Vidal S.M., Malo D., Vogan K., Skamene E. and Gros P. (1993) Natural resistance
to infection with intracellular parasites: isolation of a candidate for Bcg. Cell 73, 469-485.
[97]
Weiss M.G., Sommerfeld J. and Uplekar M.W. (2008) Social and cultural
dimensions of gender and tuberculosis. Int
J Tuberc Lung Dis 12, 829-830.
[98]
WHO (1998a) Laboratory services in TB control, Part I: Organization and
management. Geneva: World Health Organization.
[99]
WHO (1998b) Laboratory services in TB control, Part II: Microscopy. Geneva:
World Health Organization.
[100]
WHO (1998c) Laboratory services in TB control. Part III: Culture. Geneva: World
Health Organization.
[101]
WHO (1998d) Laboratory services in tuberculosis control; part I: organization
and management. Geneva.
[102]
WHO (2004) The WHO/IUATLD Global Project on Anti-Tuberculosis Drug Resistance
Surveillance. Anti-tuberculosis drug resistance in the world. Geneva: WHO.
[103]
WHO (2005) Global Tuberculosis Control Report: World Health Organization.
[104]
WHO (2006) The Stop TB Strategy. Geneva.
[105]
WHO (2007) Use of Liquid TB Culture and Drug Susceptibility Testing in Low- and
Medium-income Settings: World Health Organization.
[106]
WHO (2008a) Policy Guidance on Drug Susceptibility Testing (DST) of Second-line
Anti-Tuberculosis Drugs. Geneva: World Health Organization.
[107]
WHO (2008b) Policy Statement. Molecular Line Probe Assay for Rapid Screening of
Patients at Risk of Multidrug-resistant (MDR) TB. Geneva: World Health
Organization.
[108]
WHO (2010a) Policy Statement on Fluorescent Light Emitting Diode Microscopy for
Diagnosis of Tuberculosis: World Health Organization.
[109]
WHO (2010b) Policy Statement on Non-commercial Culture and DST Methods for
rapid screening of Patients at Risk of Multidrug-resistant Tuberculosis.
Geneva: World Health Organization.
[110]
WHO (2011a) Intensifying TB case detection in Ghana.
[111]
WHO (2011b) Policy Statement Automated real-time nucleic acid amplification
technology for rapid and simultaneous detection of tuberculosis and rifampicin
resistance: Xpert MTB/RIF system Geneva: World Health Organization.
[112]
Wolfart W. (1990) Surgical treatment of tuberculosis and its
modifications—collapse therapy and resection treatment and their present-day
sequelae. OffentlGesundheitswes 52,
506–511.
[113] Yamamoto Y., Saito H., Setogawa T. and Tomioka H.
(1991) Sex differences in host resistance to Mycobacterium marinum infection in
mice. Infect Immun 59, 4089-4096.
[114] Yamamoto Y., Tomioka H., Sato K., Saito H., Yamada
Y. and Setogawa T. (1990) Sex differences in the susceptibility of mice to
infection induced by Mycobacterium intracellulare. Am Rev Respir Dis 142, 430-433.
[115] Young J.C. and Garro L.Y. (1982) Variation in the
choice of treatment in two Mexican communities. Soc Sci Med 16, 1453-1465.
[116] Zimmermann M.B. and Hurrell R.F. (2007) Nutritional
iron deficiency. Lancet 370, 511-520.
[117] Zink A.R., Sola C., Reischl U., Grabner W., Rastogi
N., Wolf H. and Nerlich A.G. (2003) Characterization of Mycobacterium
tuberculosis complex DNAs from Egyptian mummies by spoligotyping. J Clin Microbiol 41, 359-367.